Israel Englander Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $56.6 Million - $99.3 Million	680,426 Added 5929.12%	691,902 $101 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $2.62 Million - $3.4 Million	-23,768 Reduced 67.44%	11,476 $1.36 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $2.53 Million - $3.76 Million	-25,335 Reduced 41.82%	35,244 $4.86 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $5.67 Million - $7.97 Million	57,379 Added 1793.09%	60,579 $8.42 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $3.32 Million - $5.29 Million	-50,416 Reduced 94.03%	3,200 $311,000
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $1.92 Million - $2.75 Million	-29,997 Reduced 35.88%	53,616 $3.67 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $4.52 Million - $6.82 Million	69,396 Added 488.12%	83,613 $7.17 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $375,612 - $495,917	-6,362 Reduced 30.92%	14,217 $924,000
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $2.09 Million - $5.35 Million	-72,064 Reduced 77.79%	20,579 $1.51 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $3.79 Million - $5.34 Million	92,643 New	92,643 $5.04 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $2.78 Million - $3.69 Million	-74,490 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$39.79 - $67.01 $143 Million - $241 Million	-3,590,123 Reduced 97.97%	74,490 $3.26 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $142 Million - $240 Million	3,575,433 Added 4009.23%	3,664,613 $94.3 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $1.68 Million - $2.6 Million	48,741 Added 120.53%	89,180 $4.59 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $132,328 - $190,819	4,448 Added 12.36%	40,439 $1.5 Million
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $1.98 Million - $2.6 Million	-60,500 Reduced 62.7%	35,991 $1.35 Million
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $578,406 - $1.04 Million	-24,488 Reduced 20.24%	96,491 $3.81 Million
Q1 2018 May 15, 2018	SELL	$22.49 - $34.56 $3.5 Million - $5.37 Million	-155,471 Reduced 56.24%	120,979 $3.12 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $5.65 Million - $9.83 Million	276,450	276,450 $7.46 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account